Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain

Wenling Dai(Nanjing University of Chinese Medicine), Jihua Liu(China Pharmaceutical University), Ji-Fa Fan(China Pharmaceutical University), Bin Ma(Gansu Provincial Maternal and Child Health Hospital), Wanli Zhao(China Pharmaceutical University), Yini Bao(China Pharmaceutical University), Shanshan Li(Shanghai Jiao Tong University), Boyang Yu(Inner Mongolia Medical University)
Journal of Advanced Research
August 12, 2020
Cited by 22


Related Papers